The near-term outlook for ClearPoint's biopharma business is also now clouded by FDA uncertainty around uniQure's AMT-130.
Memphis Art Museum's construction won't be finished for about a year, but that doesn't mean no "art" is on display at the ...
The spending bill, passed by Congress and signed by President Donald Trump on Wednesday, includes new federal restrictions on ...
2025 Revenue Guidance -- Management expects full-year revenue of $30 million to $40 million, with Q4 guidance of $5 million ...
Q3 2025 Earnings Call Transcript November 12, 2025 BiomX Inc. beats earnings expectations. Reported EPS is $0, expectations ...
HopSkipDrive Elevates Safety Standards with New CareDriver Education Programs and Enhanced Certification Process School ...
Zacks Investment Research on MSN
Stay Ahead of the Game With Dolby Laboratories (DLB) Q4 Earnings: Wall Street's Insights on Key Metrics
Analysts on Wall Street project that Dolby Laboratories (DLB) will announce quarterly earnings of $0.70 per share in its forthcoming report, representing a decline of 13.6% year over year. Revenues ...
TORONTO - Martinrea International Inc. reported $35.8 million in profit during the third quarter, up from $14.2 million ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback